Clinical Trial Update: To Evaluate the Efficacy and Safety/Tolerability Profiles of G-CSF in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety/tolerability of G-CSF in subjects with mild to moderate Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• G-CSF (granulocyte colony-stimulating factor)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED